Your Basket is currently empty

Your Bookshelf is empty!

Your Basket is currently empty


Pharmaceutical, Biological and Chemical Patents

A Handbook

By: Maximilian Haedicke, Marco Stief, Dirk Bühler
Media of Pharmaceutical, Biological and Chemical Patents
See larger image
Published: 18-03-2020
Format: Hardback
Edition: 1st
Extent: 250
ISBN: 9781849464901
Imprint: Beck/Hart
Dimensions: 240 x 160 mm
RRP : £200.00

: (?)

Buying pre-order items

Your pre-order item will usually be shipped on the publishing date of the book.


You will receive an email with a download link for the ebook on the publication date.


You will not be charged for pre-ordered books until they are available to be shipped. Pre-ordered ebooks will not be charged for until they are available for download.

Amending or cancelling your order

For orders that have not been shipped you can usually make changes to pre-orders up to 24 hours before the publishing date.

Delivery & Returns

Tell others about this product

Loren Epson

About Pharmaceutical, Biological and Chemical Patents

The topic of chemical and biological patents is of special importance in European and German patent law. The highly technical nature of patents in this area gives rise to special problems for patent lawyers in understanding, for instance, structural alterations like polymorphism and enantiomerism, which lead to a derivative of a substance that is comprised in the prior art. It is a legal question whether and under what circumstances such alterations are treated as novel, and in which cases they are part of the state of the art. Even if a substance is prior art, a new medical use can be patented. Dealing with natural occurrences of a substance is also a problem for patent law, as is the difficulty of understanding how different identifications of a substance and the resulting patents interrelate with each other. This book provides an expert overview of all these questions.

Past decisions of the European Court of Justice (ECJ) concerning broccoli and tomato patents, as well as embryonic stem cells, have highlighted the importance of this field of law. Most of the proceedings regarding chemical and biological patents have been held in German courts, and the German jurisprudence has often been the basis for ECJ decisions. Thus, German case law is used to illustrate the commentary.

Bookmark and Share